Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.1.161

Monitoring microRNAs Using a Molecular Beacon in CD133+/CD338+ Human Lung Adenocarcinoma-initiating A549 Cells  

Yao, Quan (Diagnosis and Treatment Center of Cancer, Chengdu Military General Hospital)
Sun, Jian-Guo (Institute of Cancer, Xinqiao Hospital, Third Military Medical University)
Ma, Hu (Department of Oncology, Affiliated Hospital of Zunyi Medical University)
Zhang, An-Mei (Institute of Cancer, Xinqiao Hospital, Third Military Medical University)
Lin, Sheng (Department of Oncology, Affiliated Hospital of Luzhou Medical College)
Zhu, Cong-Hui (Institute of Cancer, Xinqiao Hospital, Third Military Medical University)
Zhang, Tao (Diagnosis and Treatment Center of Cancer, Chengdu Military General Hospital)
Chen, Zheng-Tang (Institute of Cancer, Xinqiao Hospital, Third Military Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.1, 2014 , pp. 161-166 More about this Journal
Abstract
Lung cancer is the most common causes of cancer-related deaths worldwide, and a lack of effective methods for early diagnosis has greatly impacted the prognosis and survival rates of the affected patients. Tumor-initiating cells (TICs) are considered to be largely responsible for tumor genesis, resistance to tumor therapy, metastasis, and recurrence. In addition to representing a good potential treatment target, TICs can provide clues for the early diagnosis of cancer. MicroRNA (miRNA) alterations are known to be involved in the initiation and progression of human cancer, and the detection of related miRNAs in TICs is an important strategy for lung cancer early diagnosis. As Hsa-miR-155 (miR-155) can be used as a diagnostic marker for non-small cell lung cancer (NSCLC), a smart molecular beacon of miR-155 was designed to image the expression of miR-155 in NSCLC cases. TICs expressing CD133 and CD338 were obtained from A549 cells by applying an immune magnetic bead isolation system, and miR-155 was detected using laser-scanning confocal microscopy. We found that intracellular miR-155 could be successfully detected using smart miR-155 molecular beacons. Expression was higher in TICs than in A549 cells, indicating that miR-155 may play an important role in regulating bio-behavior of TICs. As a non-invasive approach, molecular beacons could be implemented with molecular imaging to diagnose lung cancer at early stages.
Keywords
microRNA; non-small cell lung cancer; tumor-initiating cell; molecular beacon; molecular imaging;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Zhou S, Schuetz JD, Bunting KD, et al (2001). The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the sidepopulation phenotype. Nat Med, 7, 1028-34.   DOI   ScienceOn
2 Wu K, Ding J, Chen C, et al (2012). Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Hepatology, 56, 2255-67.   DOI
3 Tyagi S, Kramer FR (1996). Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol, 14, 303-8.   DOI   ScienceOn
4 Wang B, Majumder S, Nuovo G, et al (2009a). Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology, 50, 1152-61.   DOI
5 Wang QZ, Xu W, Habib N, Xu R (2009b). Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. Curr Cancer Drug Targets, 9, 572-94.   DOI   ScienceOn
6 Xie Y, Todd NW, Liu Z, et al (2010). Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer, 67, 170-6.   DOI
7 Yanaihara N, Caplen N, Bowman E, et al (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-98.   DOI   ScienceOn
8 Yao Q, Zhang AM, Ma H, et al (2012). Novel molecular beacons to monitor microRNAs in non-small-cell lung cancer. Mol Cell Probes, 26, 182-7.   DOI
9 Yin S, Li J, Hu C, et al (2007). CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer, 120, 1444-50.   DOI
10 Yu F, Deng H, Yao H, et al (2010). Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene, 29, 4194-204.   DOI   ScienceOn
11 Yu F, Jiao Y, Zhu Y, et al (2012). MicroRNA 34c gene downregulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells. J Biol Chem, 287, 465-73.   DOI
12 Meng X, Li M, Wang X, Wang Y, Ma D (2009). Both CD133+ and CD133-subpopulations of A549 and H446 cells contain cancer-initiating cells. Cancer Sci, 100, 1040-6.   DOI   ScienceOn
13 O'Brien CA, Pollett A, Gallinger S, Dick JE (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445, 106-10.   DOI   ScienceOn
14 Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al (2007). Identification and expansion of human colon-cancerinitiating cells. Nature, 445, 111-5.   DOI   ScienceOn
15 Santangelo P, Nitin N, Bao G (2006). Nanostructured probes for RNA detection in living cells. Ann Biomed Eng, 34, 39-50.   DOI
16 Seo DC, Sung JM, Cho HJ, et al (2007). Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells. Mol Cancer, 6, 75.   DOI
17 Singh SK, Clarke ID, Terasaki M, et al (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res, 63, 5821-8.
18 Singh SK, Hawkins C, Clarke ID, et al (2004). Identification of human brain tumour initiating cells. Nature, 432, 396-401.   DOI   ScienceOn
19 Suetsugu A, Nagaki M, Aoki H, et al (2006). Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/ progenitor cells. Biochem Biophys Res Commun, 351, 820-824.   DOI   ScienceOn
20 Sullivan JP, Minna JD, Shay JW (2010). Evidence for selfrenewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy. Cancer Metastasis Rev, 29, 61-72.   DOI
21 Tyagi S, Bratu DP, Kramer FR (1998). Multicolor molecular beacons for allele discrimination. Nat Biotechnol, 16, 49-53.   DOI   ScienceOn
22 Ho MM, Ng AV, Lam S, Hung JY (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res, 67, 4827-33.   DOI   ScienceOn
23 Jemal A, Siegel R, Ward E, et al (2006). Cancer statistics, 2006. CA Cancer J Clin, 56, 106-30.   DOI   ScienceOn
24 Henschke CI, Yankelevitz DF, Libby DM, et al (2006). Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med, 355, 1763-71.   DOI   ScienceOn
25 Hermann PC, Huber SL, Herrler T, et al (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 1, 313-23.   DOI   ScienceOn
26 Jiang S, Zhang HW, Lu MH, et al (2010). MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res, 70, 3119-27.   DOI   ScienceOn
27 Juan D, Alexe G, Antes T, et al (2010). Identification of a microRNA panel for clear-cell kidney cancer. Urology, 75, 835-41.   DOI
28 Kim Y, Yang CJ, Tan W (2007). Superior structure stability and selectivity of hairpin nucleic acid probes with an L-DNA stem. Nucleic Acids Res, 35, 7279-87.   DOI
29 Kong W, He L, Coppola M, et al (2010). MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem, 285, 17869-79.   DOI   ScienceOn
30 Krol J, Loedige I, Filipowicz W (2010). The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet, 11, 597-610.
31 Kwak PB, Iwasaki S, Tomari Y (2010). The microRNA pathway and cancer. Cancer Sci, 101, 2309-15.   DOI
32 Eramo A, Lotti F, Sette G, et al (2008). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ, 15, 504-14.   DOI   ScienceOn
33 Kwon MJ, Shin YK (2013). Regulation of ovarian cancer stem cells or tumor-initiating cells. Int J Mol Sci, 14, 6624-48.   DOI
34 Garofalo M, Croce CM (2011). microRNAs: Master regulators as potential therapeutics in cancer. Annu Rev Pharmacol Toxicol, 51, 25-43.   DOI
35 Elton TS, Selemon H, Elton SM, Parinandi NL (2012). Regulation of the MIR155 host gene in physiological and pathological processes. Gene, 532, 1-12
36 Adhikari AS, Agarwal N, Iwakuma T (2011). Metastatic potential of tumor-initiating cells in solid tumors. Front Biosci, 16, 1927-38.   DOI
37 Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.   DOI   ScienceOn
38 Garzon R, Calin GA, Croce CM (2009). MicroRNAs in Cancer. Annu Rev Med, 60, 167-79.   DOI   ScienceOn
39 Georgantas RW, Hildreth R, Morisot S, et al (2007). CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA, 104, 2750-5.   DOI   ScienceOn
40 Greither T, Grochola LF, Udelnow A, et al (2010). Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer, 126, 73-80.   DOI   ScienceOn
41 Guo W, Lasky JL, Wu H (2006). Cancer stem cells. Pediatr Res, 59, 59-64.   DOI
42 Habbe N, Koorstra JB, Mendell JT, et al (2009). MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther, 8, 340-6.   DOI   ScienceOn
43 Chen CZ (2005). MicroRNAs as oncogenes and tumor suppressors. N Engl J Med, 353, 1768-71.   DOI   ScienceOn
44 Hatfield S, Ruohola-Baker H (2008). microRNA and stem cell function. Cell Tissue Res, 331, 57-66.   DOI   ScienceOn
45 Bertolini G, Roz L, Perego P, et al (2009). Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA, 106, 16281-6.   DOI   ScienceOn
46 Bushati N, Cohen SM (2007). microRNA functions. Annu Rev Cell Dev Biol, 23, 175-205.   DOI   ScienceOn
47 Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res, 65, 10946-51.   DOI   ScienceOn
48 Donnem T, Eklo K, Berg T, et al (2011). Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization. J Transl Med, 9, 6.   DOI   ScienceOn
49 Ryu JK, Hong SM, Karikari CA, et al (2010). Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology, 10, 66-73.   DOI   ScienceOn
50 Zandberga E, Kozirovskis V, Abols A, et al (2013). Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes Chromosomes Cancer, 52, 356-69.   DOI
51 Faraoni I, Antonetti FR, Cardone J, Bonmassar E (2009). miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta, 1792, 497-505.   DOI